“…Due to the tremendous application in marketed drugs, chemical and enzymatic methods of producing Ltert-leucine (L-tle), which is widely used as a chiral building block in the synthesis of anti-tumor and antivirus drugs [1,2], such as atazanavir, telaprevir and boceprevir, have been developed rapidly. However, the disadvantages were signi cant and pervasive existed in most chiral l-tert chemical catalysis producing process, including energy-consuming, environmentally-unfriendly, and low conversion and enantioselectivity [3,4]. The greener biocatalysts, such as leucine dehydrogenase [5], branched chain aminotransferase [6], amidases [7], and proteases [8], penicillinyl enzymes [9], lipases [10], have been developed and applied in L-tle enzymatically producing process over the past few decades.…”